BNP Paribas Financial Markets’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $936K | Buy |
63,953
+16,732
| +35% | +$248K | ﹤0.01% | 3360 |
|
|
2026
Q1 | $685K | Sell |
47,221
-24,960
| -35% | -$290K | ﹤0.01% | 3409 |
|
|
2025
Q4 | $694K | Buy |
72,181
+56,918
| +373% | +$545K | ﹤0.01% | 3375 |
|
|
2025
Q3 | $143K | Buy |
15,263
+13,960
| +1,071% | +$133K | ﹤0.01% | 4153 |
|
|
2025
Q2 | $13.8K | Sell |
1,303
-7,763
| -86% | -$98K | ﹤0.01% | 4754 |
|
|
2025
Q1 | $136K | Sell |
9,066
-5,382
| -37% | -$89.5K | ﹤0.01% | 3910 |
|
|
2024
Q4 | $238K | Buy |
14,448
+11,607
| +409% | +$229K | ﹤0.01% | 3763 |
|
|
2024
Q3 | $70.2K | Sell |
2,841
-149
| -5% | -$3.86K | ﹤0.01% | 3547 |
|
|
2024
Q2 | $75.7K | Sell |
2,990
-19,250
| -87% | -$499K | ﹤0.01% | 3357 |
|
|
2024
Q1 | $565K | Buy |
22,240
+3,217
| +17% | +$77.8K | ﹤0.01% | 2776 |
|
|
2023
Q4 | $431K | Buy |
19,023
+4,852
| +34% | +$100K | ﹤0.01% | 2873 |
|
|
2023
Q3 | $264K | Buy |
14,171
+4,224
| +42% | +$87.6K | ﹤0.01% | 3000 |
|
|
2023
Q2 | $258K | Sell |
9,947
-6,928
| -41% | -$185K | ﹤0.01% | 2918 |
|
|
2023
Q1 | $485K | Buy |
16,875
+7,379
| +78% | +$220K | ﹤0.01% | 2755 |
|
|
2022
Q4 | $281K | Sell |
9,496
-8,457
| -47% | -$241K | ﹤0.01% | 2866 |
|
|
2022
Q3 | $427K | Buy |
17,953
+12,961
| +260% | +$298K | ﹤0.01% | 3079 |
|
|
2022
Q2 | $111K | Sell |
4,992
-296
| -6% | -$6.6K | ﹤0.01% | 3323 |
|
|
2022
Q1 | $133K | Sell |
5,288
-4,180
| -44% | -$127K | ﹤0.01% | 3275 |
|
|
2021
Q4 | $339K | Sell |
9,468
-5,705
| -38% | -$228K | ﹤0.01% | 3200 |
|
|
2021
Q3 | $646K | Buy |
15,173
+8,616
| +131% | +$355K | ﹤0.01% | 2629 |
|
|
2021
Q2 | $284K | Sell |
6,557
-1,462
| -18% | -$62.3K | ﹤0.01% | 2770 |
|
|
2021
Q1 | $327K | Buy |
8,019
+5,467
| +214% | +$207K | ﹤0.01% | 2803 |
|
|
2020
Q4 | $116K | Sell |
2,552
-971
| -28% | -$36.9K | ﹤0.01% | 3141 |
|
|
2020
Q3 | $125K | Sell |
3,523
-13,689
| -80% | -$494K | ﹤0.01% | 2993 |
|
|
2020
Q2 | $649K | Sell |
17,212
-15,031
| -47% | -$495K | ﹤0.01% | 1983 |
|
|
2020
Q1 | $932K | Buy |
32,243
+28,747
| +822% | +$1.16M | ﹤0.01% | 1958 |
|
|
2019
Q4 | $181K | Buy |
3,496
+990
| +40% | +$57.5K | ﹤0.01% | 3002 |
|
|
2019
Q3 | $138K | Buy |
2,506
+964
| +63% | +$49.5K | ﹤0.01% | 2943 |
|
|
2019
Q2 | $62.6K | Sell |
1,542
-1,349
| -47% | -$49.2K | ﹤0.01% | 3288 |
|
|
2019
Q1 | $87.4K | Buy |
2,891
+2,257
| +356% | +$77.3K | ﹤0.01% | 3203 |
|
|
2018
Q4 | $21.3K | Buy |
634
+135
| +27% | +$4.87K | ﹤0.01% | 3087 |
|
|
2018
Q3 | $21K | Sell |
499
-1,227
| -71% | -$48.5K | ﹤0.01% | 3397 |
|
|
2018
Q2 | $55.2K | Sell |
1,726
-3,003
| -64% | -$124K | ﹤0.01% | 3076 |
|
|
2018
Q1 | $235K | Sell |
4,729
-9,364
| -66% | -$529K | ﹤0.01% | 2704 |
|
|
2017
Q4 | $760K | Buy |
14,093
+6,820
| +94% | +$377K | ﹤0.01% | 2178 |
|
|
2017
Q3 | $422K | Buy |
7,273
+2,958
| +69% | +$155K | ﹤0.01% | 2076 |
|
|
2017
Q2 | $213K | Buy |
4,315
+126
| +3% | +$5.8K | ﹤0.01% | 2417 |
|
|
2017
Q1 | $182K | Sell |
4,189
-302
| -7% | -$14.4K | ﹤0.01% | 2259 |
|
|
2016
Q4 | $220K | Buy |
4,491
+2,227
| +98% | +$103K | ﹤0.01% | 2158 |
|
|
2016
Q3 | $108K | Sell |
2,264
-2,421
| -52% | -$120K | ﹤0.01% | 2063 |
|
|
2016
Q2 | $251K | Buy |
4,685
+2,184
| +87% | +$103K | ﹤0.01% | 1815 |
|
|
2016
Q1 | $112K | Sell |
2,501
-337
| -12% | -$13.7K | ﹤0.01% | 1751 |
|
|
2015
Q4 | $108K | Sell |
2,838
-332
| -10% | -$12.7K | ﹤0.01% | 2284 |
|
|
2015
Q3 | $101K | Buy |
3,170
+1,953
| +160% | +$68.1K | ﹤0.01% | 2389 |
|
|
2015
Q2 | $40.2K | Buy |
1,217
+866
| +247% | +$30.9K | ﹤0.01% | 2621 |
|
|
2015
Q1 | $14.5K | Buy |
+351
| New | +$14.2K | ﹤0.01% | 2541 |
|
|
2014
Q4 | – | Sell |
-1,070
| Closed | -$39.2K | – | 2044 |
|
|
2014
Q3 | $39.2K | Buy |
1,070
+1,018
| +1,958% | +$44K | ﹤0.01% | 2732 |
|
|
2014
Q2 | $2.41K | Buy |
52
+9
| +21% | +$400 | ﹤0.01% | 2995 |
|
|
2014
Q1 | $1.84K | Sell |
43
-136
| -76% | -$5.05K | ﹤0.01% | 2687 |
|
|
2013
Q4 | $6.83K | Buy |
+179
| New | +$5.52K | ﹤0.01% | 2898 |
|
Other funds holding ANIK
CP
CM
BNP Paribas Financial Markets's ANIK Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Anika Therapeutics (ANIK) stake by 35% in Q2 2026, buying an estimated $248K and bringing the position to 63,953 shares worth $936K. The position accounts for ﹤0.01% of the portfolio, ranked #3360.
BNP Paribas Financial Markets first reported a position in ANIK in Q4 2013 and has held it in 50 quarters since. 123 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.
- BNP Paribas Financial Markets held 63,953 shares of Anika Therapeutics worth $936K as of Q2 2026.
- BNP Paribas Financial Markets bought 16,732 Anika Therapeutics shares in Q2 2026, an estimated $248K.
- Anika Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3360 holding.
- BNP Paribas Financial Markets first reported a position in Anika Therapeutics in Q4 2013 and has held it in 50 quarters since.
- 123 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.